These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145 [TBL] [Abstract][Full Text] [Related]
25. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome. Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286 [TBL] [Abstract][Full Text] [Related]
26. The hyper-IgE syndromes. Freeman AF; Holland SM Immunol Allergy Clin North Am; 2008 May; 28(2):277-91, viii. PubMed ID: 18424333 [TBL] [Abstract][Full Text] [Related]
27. Clinical Profile of Hyper-IgE Syndrome in India. Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S Front Immunol; 2021; 12():626593. PubMed ID: 33717144 [No Abstract] [Full Text] [Related]
28. Autosomal dominant hyper-IgE syndrome: When hematopoietic stem cell transplantation should be considered? Oikonomopoulou C; Goussetis E Pediatr Transplant; 2020 Aug; 24(5):e13699. PubMed ID: 32497403 [TBL] [Abstract][Full Text] [Related]
29. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China. Xie L; Hu X; Li Y; Zhang W; Chen L Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. Schimke LF; Sawalle-Belohradsky J; Roesler J; Wollenberg A; Rack A; Borte M; Rieber N; Cremer R; Maass E; Dopfer R; Reichenbach J; Wahn V; Hoenig M; Jansson AF; Roesen-Wolff A; Schaub B; Seger R; Hill HR; Ochs HD; Torgerson TR; Belohradsky BH; Renner ED J Allergy Clin Immunol; 2010 Sep; 126(3):611-7.e1. PubMed ID: 20816194 [TBL] [Abstract][Full Text] [Related]
31. Phenotyping and long-term follow up of patients with hyper IgE syndrome. Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075 [TBL] [Abstract][Full Text] [Related]
32. Hyper-IgE syndromes: reviewing PGM3 deficiency. Yang L; Fliegauf M; Grimbacher B Curr Opin Pediatr; 2014 Dec; 26(6):697-703. PubMed ID: 25365149 [TBL] [Abstract][Full Text] [Related]
33. Hyperimmunoglobulin E syndromes in pediatrics. Zhang Q; Su HC Curr Opin Pediatr; 2011 Dec; 23(6):653-8. PubMed ID: 21970826 [TBL] [Abstract][Full Text] [Related]
34. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. Sassi A; Lazaroski S; Wu G; Haslam SM; Fliegauf M; Mellouli F; Patiroglu T; Unal E; Ozdemir MA; Jouhadi Z; Khadir K; Ben-Khemis L; Ben-Ali M; Ben-Mustapha I; Borchani L; Pfeifer D; Jakob T; Khemiri M; Asplund AC; Gustafsson MO; Lundin KE; Falk-Sörqvist E; Moens LN; Gungor HE; Engelhardt KR; Dziadzio M; Stauss H; Fleckenstein B; Meier R; Prayitno K; Maul-Pavicic A; Schaffer S; Rakhmanov M; Henneke P; Kraus H; Eibel H; Kölsch U; Nadifi S; Nilsson M; Bejaoui M; Schäffer AA; Smith CI; Dell A; Barbouche MR; Grimbacher B J Allergy Clin Immunol; 2014 May; 133(5):1410-9, 1419.e1-13. PubMed ID: 24698316 [TBL] [Abstract][Full Text] [Related]
35. Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES). Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Hsieh MY; Huang YC; Kuo HC; Yang KD; Yu HR; Jaing TH; Yang CH J Clin Immunol; 2011 Apr; 31(2):272-80. PubMed ID: 21120687 [TBL] [Abstract][Full Text] [Related]
36. Multi-Omics Profiling in PGM3 and STAT3 Deficiencies: A Tale of Two Patients. Jacob M; Masood A; Abdel Rahman AM Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768728 [TBL] [Abstract][Full Text] [Related]
37. Hyper-IgE syndrome with a novel STAT3 mutation-a single center study from India. Saikia B; Suri D; Goel S; Rawat A; Minz RW; Gupta A; Sharma S; Ohara O; Imai K; Nonoyama S; Sehgal S; Singh S Asian Pac J Allergy Immunol; 2014 Dec; 32(4):321-7. PubMed ID: 25543043 [TBL] [Abstract][Full Text] [Related]
39. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S). Liu JY; Li Q; Chen TT; Guo X; Ge J; Yuan LX Eur J Pediatr; 2011 May; 170(5):661-6. PubMed ID: 21107604 [TBL] [Abstract][Full Text] [Related]